Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Oct 25;9(1):246.
doi: 10.1186/s13643-020-01498-0.

Effects of oncological care pathways in primary and secondary care on patient, professional and health systems outcomes: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Effects of oncological care pathways in primary and secondary care on patient, professional and health systems outcomes: a systematic review and meta-analysis

Jolanda C van Hoeve et al. Syst Rev. .

Abstract

Background: Pathways are frequently used to improve care for cancer patients. However, there is little evidence about the effects of pathways used in oncological care. Therefore, we performed a systematic review and meta-analysis aiming to identify and synthesize existing literature on the effects of pathways in oncological care.

Methods: All patients diagnosed with cancer in primary and secondary/tertiary care whose treatment can be characterized as the strategy "care pathways" are included in this review. A systematic search in seven databases was conducted to gather evidence. Studies were screened by two independent reviewers. Study outcomes regarding patients, professionals, and system level were extracted from each study.

Results: Out of 13,847 search results, we selected 158 articles eligible for full text assessment. One hundred fifty studies were excluded and the remaining eight studies represented 4786 patients. Most studies were conducted in secondary/tertiary care. Length of stay (LOS) was the most common used indicator, and was reported in five studies. Meta-analysis based on subgroups showed an overall shorter LOS regarding gastric cancer (weighted mean difference (WMD)): - 2.75, CI: - 4.67 to - 0.83) and gynecological cancer (WMD: - 1.58, CI: - 2.10 to - 1.05). Costs were reported in six studies and most studies reported lower costs for pathway groups.

Conclusions: Despite the differences between the included studies, we were able to present an evidence base for cancer care pathways performed in secondary/tertiary care regarding the positive effects of LOS in favor of cancer care pathways.

Systematic review registration: PROSPERO CRD42017057592.

Keywords: Cancer; Care maps; Care pathways; Clinical pathways; Integrated care pathways; Oncology; Systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Reported complications
Fig. 2
Fig. 2
Reported readmissions
Fig. 3
Fig. 3
Reported effects on LOS
Fig. 4
Fig. 4
Subgroup analyses of the effects on LOS

References

    1. De Bleser L, Depreitere R, De Waele K, Vanhaecht K, Vlayen J, Sermeus W. Defining pathways. J Nurs Manag. 2006;14:553–563. doi: 10.1111/j.1365-2934.2006.00702.x. - DOI - PubMed
    1. Kinsman L, Rotter T, James E, Snow P, Willis J. What is a clinical pathway? Development of a definition to inform the debate. BMC Med. 2010;8:31. doi: 10.1186/1741-7015-8-31. - DOI - PMC - PubMed
    1. Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. Br Med J. 1998;316:133–137. doi: 10.1136/bmj.316.7125.133. - DOI - PMC - PubMed
    1. Vanhaecht K, Panella M, Van Zelm R, Sermeus W. Is there a future for pathways? Five pieces of the puzzle. Int J Care Pathways. 2009;13:82–86. doi: 10.1258/jicp.2009.009013. - DOI
    1. Vanhaecht K, Sermeus W, Peers J, Deneckere S, Lodewijckx C, Leigheb F, et al. The European Quality of Care Pathway (EQCP) Study: history, project management and approach. Int J Care Pathways. 2010;14:52–56. doi: 10.1258/jicp.2010.010015. - DOI